Bruker (BRKR) Launches The MALDI Biotyper Sirius System
Zacks Investment Research | Jun 24, 2019 08:16AM ET
Bruker Corporation (NASDAQ:BRKR) launched the new MALDI Biotyper sirius system for all previously FDA-approved assays and research-use-only (RUO) MALDI Biotyper (MBT) reference libraries at the ASM Microbe Conference 2019. These reference libraries are used for near-universal, fast and cost-efficient microbial identification from cultures in microbiology. The launch is a milestone for Bruker in the field of assay research and clinical studies for fast antibiotic-resistance testing.
More About MALDI Biotyper Sirius
The MALDI Biotyper sirius supports novel negative-ion mode assay research and clinical studies in fast antibiotic-resistance testing. The high-end system reinforces the utility of the standard MALDI Biotyper and the high-throughput MALDI Biotyper smart.
In addition to all routine clinical FDA-approved identification assays, new fast assays (that can identify colistin resistance in gram-negative bacteria) can now be developed and confirmed on the MALDI Biotyper Sirius on the same instrument.
The new MBT sirius utilizes the proprietary smartbeam solid-state laser with a 200-Hz repetition rate and a lifetime of 500 million shots. The high-performance vacuum system facilitates a faster exchange of target plates in laboratory workflows, where multiple technicians prepare targets independently. Moreover, this system cuts downtime after service or preventive maintenance, which can be completed on the same day.
In addition, Bruker launched the MBT-STAR assays for Selective-Testing of Antibiotic Resistance for carbapenems and for cephalosporins as RUO assays to support U.S. research and validation studies for the swift identification of antibiotic resistance.
Market Prospects
Per Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.